Dr. Arturo Urrios

Dr. Arturo Urrios

Senior Associate

"Things are only impossible until they are not."

— Jean–Luc Picard


Arturo joined Wellington Partners as an Associate in 2019 and was promoted to Senior Associate in 2020.

Prior to joining Wellington, Arturo worked as an Investment Analyst at the Life Science Team of M Ventures in the Netherlands, where he was involved in several investment processes including Riffyn, DNA Script, Plexium and Pantheon Biosciences. Prior to joining M Ventures, Arturo completed postdoctoral studies developing synthetic biology approaches for type 1 diabetes treatment while starting a personal project as a winemaker and freelancing in different start-ups aiding with strategy and business development.

Arturo holds a BSc in Human Biology, an MSc in Biomedical Research, a PhD in Biomedicine and an MBA. Arturo performed his thesis in the Cell Signaling Research Group at Pompeu Fabra University, Barcelona and the Folch lab at University of Washington, Seattle, in the fields of synthetic biology, biological computation, 3D printing and microfluidics, resulting in several publications in prestigious journals. During his academic trajectory, he received multiple distinctions such as a National graduation award, La Caixa PhD fellowship, EMBO short term fellowship and an extraordinary PhD award.

Besides his daily activities at Wellington, Arturo is actively involved in the European Life Science startup ecosystem advising on different programs including the BII advisory group.